Hidenori Hamai Articles of Articles
-
Generic Drug Companies Ordered to Pay Largest Damages Ever
Summary of the JudgmentOn May 27, 2025, the IPHC ruled that the manufacturing and sales of "Nalfurafin Hydrochloride OD Tablets" by generic drug manufacturers Sawai and Fuso constitute infringement of the patent rights in question, and granted Toray a claim for damages. Sawai was ordered to pay appr
-
Preliminary Injunction against Generic Manufacturer Allegedly Infringing BMS Patent
On November 29, 2023, the Japanese subsidiary biopharmaceutical corporation, Bristol Myers Squibb (BMS), announced that the Tokyo District Court issued a preliminary injunction order against Sawai Pharmaceutical Co., Ltd., a Japanese generic drug manufacturer, that prohibits sales and manufacture of